Published in Mol Cell Biol on September 01, 2001
A novel function of eIF2alpha kinases as inducers of the phosphoinositide-3 kinase signaling pathway. Mol Biol Cell (2007) 1.32
NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility. Mol Biol Cell (2007) 1.18
Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. PLoS Pathog (2011) 1.10
PI3K/Akt activity has variable cell-specific effects on expression of HIF target genes, CA9 and VEGF, in human cancer cell lines. Cancer Lett (2009) 1.04
Critical regulation of genes for tumor cell migration by AP-1. Clin Exp Metastasis (2004) 0.90
Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling. J Cell Mol Med (2014) 0.89
A peptide functionalized poly(ethylene glycol) (PEG) hydrogel for investigating the influence of biochemical and biophysical matrix properties on tumor cell migration. Biomater Sci (2014) 0.87
A quantitative comparison of human HT-1080 fibrosarcoma cells and primary human dermal fibroblasts identifies a 3D migration mechanism with properties unique to the transformed phenotype. PLoS One (2013) 0.86
Biomaterial arrays with defined adhesion ligand densities and matrix stiffness identify distinct phenotypes for tumorigenic and nontumorigenic human mesenchymal cell types. Biomater Sci (2014) 0.80
Failure-to-thrive syndrome associated with tumor formation by Madin-Darby canine kidney cells in newborn nude mice. Comp Med (2013) 0.76
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell (1992) 30.02
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell (1992) 28.36
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A (1999) 11.38
TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science (1996) 11.29
Regulation of cell death protease caspase-9 by phosphorylation. Science (1998) 11.26
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature (1999) 10.48
Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science (1997) 9.58
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature (1999) 8.42
The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A (1998) 6.98
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol (1997) 5.66
Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J (1995) 5.24
Matrix-dependent Tiam1/Rac signaling in epithelial cells promotes either cell-cell adhesion or cell migration and is regulated by phosphatidylinositol 3-kinase. J Cell Biol (1998) 4.91
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol (1995) 4.78
Ras and Rho GTPases: a family reunion. Cell (2000) 4.21
Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A (1999) 4.19
The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A (1998) 4.18
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science (1997) 3.73
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet (1997) 3.56
A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol (1997) 3.52
Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci U S A (1997) 3.48
Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway. Nature (1998) 3.31
Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol (2000) 3.23
Phosphoinositide kinases. Curr Opin Cell Biol (1996) 3.01
The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci U S A (1998) 2.99
Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit. Mol Cell Biol (1999) 2.86
Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor. Mol Cell Biol (1999) 2.35
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res (1999) 1.95
Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol (1998) 1.93
A transforming gene present in human sarcoma cell lines. Nature (1982) 1.67
How responses get more switch-like as you move down a protein kinase cascade. Trends Biochem Sci (1997) 1.65
Activators and effectors of ras p21 proteins. Curr Opin Genet Dev (1994) 1.60
Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J Biol Chem (2000) 1.49
Oncogenic Ras enhances NF-kappaB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways. J Biol Chem (1999) 1.41
Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med (Berl) (1997) 1.40
TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem (1999) 1.35
PDGF induces an early and a late wave of PI 3-kinase activity, and only the late wave is required for progression through G1. Curr Biol (1999) 1.31
Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene (1996) 1.30
Platelet-derived growth factor activates membrane-associated phosphatidylinositol 3-kinase and mediates its translocation from the cytosol. Detection of enzyme activity in detergent-solubilized cell extracts. J Biol Chem (1992) 1.18
Rac1 regulates interleukin 1-induced nuclear factor kappaB activation in an inhibitory protein kappaBalpha-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression. J Biol Chem (2000) 1.11
Signals from the Ras, Rac, and Rho GTPases converge on the Pak protein kinase in Rat-1 fibroblasts. Mol Cell Biol (1999) 1.07
Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc Natl Acad Sci U S A (1996) 1.03
Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway. Mol Cell Biol (2000) 0.93
Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells. Oncogene (1999) 0.93
Overexpression of PTEN/MMAC1 and decreased activation of Akt in human papillomavirus-infected laryngeal papillomas. Cancer Res (2000) 0.89
Rac and Cdc42 effectors. Prog Mol Subcell Biol (1999) 0.81
Role of receptor desensitization, phosphatase induction and intracellular cyclic AMP in the termination of mitogen-activated protein kinase activity in UTP-stimulated EAhy 926 endothelial cells. Biochem J (1996) 0.80
Effect of retinoids on growth factor-induced anchorage independent growth of human fibroblasts. In Vitro Cell Dev Biol (1989) 0.77
Nucleotide sequence of an RNA polymerase binding site from the DNA of bacteriophage fd. Proc Natl Acad Sci U S A (1975) 7.14
Oligonucleotide probes complementary to variable regions of ribosomal RNA discriminate between Mycoplasma species. J Gen Microbiol (1987) 4.74
The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A (1998) 4.18
Incorporation of 3H-uridine and 3H-uracil into RNA: a simple technique for the detection of mycoplasma contamination of cultured cells. Exp Cell Res (1974) 3.73
Secondhand-smoke story goes up in flames. CMAJ (1998) 3.68
Bacterial transcript imaging by hybridization of total RNA to oligonucleotide arrays. Nat Biotechnol (1998) 3.29
Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain (2008) 2.99
Characterization of a multicomponent receptor for GDNF. Nature (1996) 2.92
Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol (2001) 2.86
Synthetic oligonucleotide probes complementary to rRNA for group- and species-specific detection of mycoplasmas. Isr J Med Sci (1987) 2.76
Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A (2000) 2.65
Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science (1987) 2.52
Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene (1994) 2.45
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry (2000) 2.41
Human MN/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships. Genomics (1996) 2.34
Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci U S A (1998) 2.20
Human cell hybrids: analysis of transformation and tumorigenicity. Science (1982) 2.16
Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J (1986) 2.11
Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science (1990) 2.07
Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res (1997) 1.96
THE MECHANISM OF THE ACTION OF IODIDES ON THE NITROGEN METABOLISM. J Clin Invest (1927) 1.94
How will the new wave of women graduates change the medical profession? Can Med Assoc J (1980) 1.93
Cloned mycoplasma ribosomal RNA genes for the detection of mycoplasma contamination in tissue cultures. Science (1984) 1.92
Purification and partial characterization of the principal deoxyribonucleic acid polymerase from Mycoplasmatales. J Bacteriol (1977) 1.88
Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res (1999) 1.88
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A (2001) 1.81
Human chromosome 12 encodes a species-specific factor which increases human immunodeficiency virus type 1 tat-mediated trans activation in rodent cells. J Virol (1990) 1.80
Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival. Oncogene (2007) 1.78
Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinomas. Am J Pathol (1994) 1.69
Role of cardiac myocyte tissue factor in heart hemostasis. J Thromb Haemost (2007) 1.68
Medical education in Canada. Can Med Assoc J (1984) 1.67
Natural occurrence of deoxynivalenol, 3-acetyl-deoxynivalenol, 15-acetyl-deoxynivalenol, nivalenol, 4,7-dideoxynivalenol, and zearalenone in polish wheat. Mycotoxin Res (1990) 1.64
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 1.62
Oncogenous osteomalacia and malignancy. Clin Endocrinol (Oxf) (1992) 1.61
The tobacco industry provides a lesson in effective lobbying. CMAJ (1989) 1.60
Suppression of malignancy in human cells. Nature (1976) 1.59
c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res (1990) 1.59
Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae. J Virol (2010) 1.58
Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res (2001) 1.55
Community education for cardiovascular disease prevention. Morbidity and mortality results from the Minnesota Heart Health Program. Am J Epidemiol (1996) 1.53
Physician manpower planning: projections and pitfalls. Can Med Assoc J (1980) 1.52
Thyroid function tests are rarely abnormal in patients with severe hyperemesis gravidarum. Clin Endocrinol (Oxf) (1992) 1.48
Options for change in the NHS consultant contract. BMJ (1994) 1.47
Osteopathy: is there a place in Canadian medicine? Can Med Assoc J (1981) 1.46
Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene (1991) 1.45
Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet (1981) 1.44
Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines. Cancer Res (2000) 1.43
Selective transfer of individual human chromosomes to recipient cells. Mol Cell Biol (1985) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Molecular cytogenetic analysis of inv dup(15) chromosomes, using probes specific for the Prader-Willi/Angelman syndrome region: clinical implications. Am J Hum Genet (1994) 1.42
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. N Engl J Med (2016) 1.41
Health care among forgotten issues in forgettable federal election. CMAJ (1997) 1.40
Should South Africa be preparing for HIV-1 vaccine efficacy trials? S Afr Med J (1997) 1.40
Environmental risk factors in Parkinson's disease. Neurology (1990) 1.39
High-altitude corneal oedema associated with acetazolamide. S Afr Med J (2011) 1.39
US editorial writers put Canadian health care under microscope. CMAJ (1998) 1.39
The private sector invades Medicare's home town. CMAJ (1998) 1.39
MD crosses great divide when moving between practices in Canada, US. CMAJ (1996) 1.39
British health care issues offer Canadians a glimpse of the future. CMAJ (1992) 1.39
Dr. Lev Goldfarb: the grim life of a Russian "refusenik". Can Med Assoc J (1984) 1.38
Acute appendicitis: CT and US correlation in 100 patients. Radiology (1994) 1.37
Medicine one of many professions battered by latest recession. CMAJ (1994) 1.37
The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells. Nucleic Acids Res (1991) 1.37
Tumour nodule formation as an in vivo measure of the suppression of cellular immune response by antilymphocytic serum. Nature (1969) 1.36
Huge court fight may be in offing as Ontario college considers penalty for maverick MD. CMAJ (1999) 1.36
Atrial fibrillation. Lancet (1998) 1.35
Microcell-mediated transfer of chromosome 6 into metastatic human C8161 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene (1994) 1.35
Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron (1998) 1.34
The incidence and size of gap junctions between the bone cells in rat calvaria. Anat Embryol (Berl) (1993) 1.32
Mycoplasma contamination of cultured amniotic fluid cells: potential hazard to prenatal chromosomal diagnosis. Science (1974) 1.32
Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene (2011) 1.31
5-a-day Power Plus: process evaluation of a multicomponent elementary school program to increase fruit and vegetable consumption. Health Educ Behav (2000) 1.30
Pattern span: a tool for unwelding visuo-spatial memory. Neuropsychologia (1999) 1.29
Changes in adult cigarette smoking in the Minnesota Heart Health Program. Am J Public Health (1995) 1.29
Direct gene transfer into human cultured cells facilitated by laser micropuncture of the cell membrane. Proc Natl Acad Sci U S A (1987) 1.27
An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. Oncogene (2011) 1.26
DNA damage and p53-mediated cell cycle arrest: a reevaluation. Proc Natl Acad Sci U S A (1996) 1.22
Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix. Cytometry B Clin Cytom (2006) 1.20
Treating hypertension after stroke. BMJ (1994) 1.20
Signal transduction by wild-type and leukemogenic Abl proteins. Biochim Biophys Acta (1997) 1.20
Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency. Cancer Res (1984) 1.19
Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ (1991) 1.19
Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev (1996) 1.19
Fatal diltiazem overdose: report of four cases and review of the literature. Postgrad Med J (1993) 1.17
Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth (1970) 1.17
Driving in Parkinson's disease. Neurology (1991) 1.16
Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. Proc Natl Acad Sci U S A (1986) 1.16
c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene (2011) 1.15
Mycoplasma detection-an obligation to scientific accuracy. Isr J Med Sci (1981) 1.14
Anchorage-independent growth of normal human fibroblasts. Proc Natl Acad Sci U S A (1981) 1.13
Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci U S A (1998) 1.12
A 1-Mb physical map and PAC contig of the imprinted domain in 11p15.5 that contains TAPA1 and the BWSCR1/WT2 region. Genomics (1997) 1.12
Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci U S A (1999) 1.11
A DNA probe, D5 [D4S90] mapping to human chromosome 4p16.3. Nucleic Acids Res (1988) 1.11
Upper limits on a stochastic background of gravitational waves. Phys Rev Lett (2005) 1.11
Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases. Oncogene (2010) 1.10
Two-dimensional map of the proteome of Haemophilus influenzae. Electrophoresis (2000) 1.10
A tumor-specific membrane phosphoprotein marker in human cell hybrids. Cell (1981) 1.09
Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11. Science (1991) 1.09
Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cancer Res (1992) 1.08